My husband and I are in shock after our visit to Mass General where my husband got bone and CT scans last week. (Due to pacemaker, he can’t get an MRI) From just a 4-5 mets last year, he now has many mets up and down his spine, in ribs, shoulders, pelvic bones.
As you can see from signature below, he resumed Lupron last year, and started Zytiga six months ago in February, 2019. His PSA dropped steadily. Throughout, Alkaline Phostophase (ALP) and calcium levels have remained well within normal range. The only abnormality has been a rise in liver enzymes in the last couple months but not outrageously off the charts. At first, our oncologist, Dr. Matthew Smith, said to stop the Zytiga entirely again then possibly resume it at a lower dose. (My husband had stopped it for two weeks a month ago, restarted, but liver enzymes were up again.) Dr. Smith said this late rise in enzymes four months in was a “head scratcher” since this kind of rise usually happens in the first months. (He was reviewing the blood test results and scans for the first time while we were there.)
Then he got to the scans. He studied them for a really long time—nothing ambiguous about them—new mets in many bones despite the current low PSA 0.64. He ordered the genetic test Guardant 360, which my husband had done after the appointment, results to come in a week. Dr. Smith then said it was time to forget the Zytiga plan and arrange to start chemo in October. All three of us were rattled. The subject of ALP and calcium didn’t come up. We only thought to recheck the numbers when we got back from Boston. They’re normal. How can this be?
My husband is going to ask some questions via the portal today. What about the normal ALP and calcium? Are any of the mets in viscera (liver possibly even though reports don't show anything?)? Continue Lupron? What else should my husband ask?
At dx my husband was high Gleason 9 with a low PSA of 3.38. But seeming “success,” after nearly three years of non-stop Lupron, then a resumption of it combined with Zytiga, was based on measuring PSA, not scans. The steady PSA decline since the Lupron restart then the Zytiga misled all of us into thinking the drug regime was effective. Has anyone out there experienced seemingly good numbers masking mets' progression? For what it’s worth, my husband has no unusual pains, just the typical ADT brain fog and fatigue. He’s been running, jogging, lifting weights, motorcycling, etc. thoughout.
SIGNATURE:
AS OF 8/21/19 Husband's prostate cancer history:
Husband 70 yrs (74 now)
pacemaker; Agent Orange 6-9/14: blood in urine; DRE suspicious
biopsy 11/14: G 9 (4+5), PSA: 3.32 high Gleason, low PSA, PNI involved
11/14: Lupron 33 mos
6/15: 9 wks IMRT
9/15: .14
1/16=.093
4/16=.079
11/16=.05
2/17-5/17=.05
11/17=.08
2/18 .20
4/18 0.98
6/18: 3-4 bone mets; 7/18 3.29
8/18 PSA 9.87 Lupron re-started
Zytiga/Prednisone started 2/9/19
2/28/19 PSA 4.02 (ALP=85; ALT-23; AST=30)
4/11/19 PSA 1.80 (ALP=68; ALT=22; AST=27)
5/28/19 PSA 0.92 (ALP=65; ALT=95; AST=67
6/14/19: PSA 1.26 (ALP=62; ALT=85; AST=50)
Zytiga 2-wk break
8/2/19: PSA 0.64 (ALP=57; ALT=159; AST=92 (told to resume Zytiga)
8/16/19: PSA 0.64 (ALP=62; ALT=173; AST=103)
Bone and CT scans done
8/20/19 VISIT: Scans indicate intensity of old mets but many new ones in spine, ribs, pelvis
"Kidney, bladder and soft tissue uptake within expected physiologice limits." Chemo recommended
to begin in Oct. Oh, 3-month Lupron shot given.
Thanks for slogging through. I hadn't posted new data for awhile, so it was time to